0001438133-20-000134.txt : 20200901
0001438133-20-000134.hdr.sgml : 20200901
20200901171938
ACCESSION NUMBER: 0001438133-20-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200828
FILED AS OF DATE: 20200901
DATE AS OF CHANGE: 20200901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Susan
CENTRAL INDEX KEY: 0001582970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 201155113
MAIL ADDRESS:
STREET 1: 11045 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_159899515925296.xml
FORM 4
X0306
4
2020-08-28
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001582970
Morrison Susan
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
0
1
0
0
EVP & Chief Admin. Officer
Common Stock
2020-08-28
4
M
0
7522
18.86
A
13778
D
Common Stock
2020-08-28
4
S
0
7522
114
D
6256
D
Common Stock
2020-08-31
4
M
0
6548
18.86
A
12804
D
Common Stock
2020-08-31
4
S
0
6548
114
D
6256
D
Common Stock
2020-09-01
4
M
0
5930
18.86
A
12186
D
Common Stock
2020-09-01
4
S
0
5930
114
D
6256
D
Stock Option
18.86
2020-08-28
4
M
0
7522
0
D
Common Stock
7522.0
72478
D
Stock Option
18.86
2020-08-31
4
M
0
6548
0
D
Common Stock
6548.0
65930
D
Stock Option
18.86
2020-09-01
4
M
0
5930
0
D
Common Stock
5930.0
60000
D
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020.
The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
s/ David B. Berger, Attorney-in-Fact for Susan M. Morrison
2020-09-01